ID
20198
Description
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies; ODM derived from: https://clinicaltrials.gov/show/NCT00441337
Link
https://clinicaltrials.gov/show/NCT00441337
Keywords
Versions (1)
- 2/11/17 2/11/17 -
Uploaded on
February 11, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Carcinoma, Non-Small-Cell Lung NCT00441337
Eligibility Carcinoma, Non-Small-Cell Lung NCT00441337
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Hypersensitivity to monoclonal antibodies
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C3542957
Description
Autoimmune disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0004364
Description
Anti-pd-1 or anti-ctla-4 antibody
Data type
boolean
Alias
- UMLS CUI [1]
- C4053601
- UMLS CUI [2]
- C2986402
Description
Active infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
Immunosuppressive medications
Data type
boolean
Alias
- UMLS CUI [1]
- C0021081
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT00441337
- StudyEvent: Eligibility
C0220650 (UMLS CUI [2])
C0025284 (UMLS CUI [3])
C3542957 (UMLS CUI [1,2])
C2986402 (UMLS CUI [2])